Mumbai (Maharashtra) [India], Feb 26 (ANI): Equity benchmark indices extended their decline for the fourth consecutive session during early hours on Wednesday after massive sell-offs in global markets amid concerns over coronavirus cases spreading beyond China.
Mumbai (Maharashtra) [India], Nov 20 (ANI): Equity benchmark indices rose to new highs in a blockbuster Wednesday morning session but closed off the day's high.
Mumbai (Maharashtra) [India], Nov 7 (ANI): Equity benchmark indices traded in a narrow range on Thursday with the Nifty index closing above 12,000 mark for the first time since June 3.
Mumbai (Maharashtra) [India], Nov 7 (ANI): Sun Pharmaceutical Industries on Thursday reported a consolidated net profit for the second fiscal quarter at Rs 1,064 crore with resulting net profit margin at 13.4 per cent.
Mumbai (Maharashtra) [India], Nov 6 (ANI): Sun Pharmaceutical Industries said on Wednesday it has entered into a licensing agreement with AstraZeneca UK Ltd to introduce certain novel ready-to-use infusion oncology products in China.
Mumbai (Maharashtra) [India], Sep 4 (ANI): Equity benchmark indices were flat in a choppy trading session during early hours on Wednesday tracking subdued global cues.
Mumbai (Maharashtra) [India], Aug 19 (ANI): Equity benchmark indices ended in the green on Monday but last hour selling pressure erased all intra-day gains.
Mumbai (Maharashtra) [India], Aug 17 (ANI): Sun Pharma has entered into an exclusive licencing agreement with China Medical System Holdings (CMSH) to develop and commercialise seven generic products in Mainland China.
Mumbai (Maharashtra) [India], Aug 14 (ANI): Sun Pharmaceutical Industries said on Wednesday that it has entered into a global licensing agreement with the CSIR Indian Institute of Chemical Technology (CSIR-IICT) in Hyderabad for patents related to certain compounds.
Mumbai (Maharashtra) [India], Aug 13 (ANI): Sun Pharmaceutical on Tuesday reported a net profit of Rs 1,387 crore in the April to June quarter of 2019-20, up 31 per cent in the year-on period.
Mumbai (Maharashtra) [India], Feb 13 (ANI): Sun Pharmaceutical Industries has registered gross sales of Rs 7,657 crore in the quarter ending December 2018, marking 16 per cent growth over the same quarter in previous year.